1.
LDL-cholesterol concentrations: a genome-wide association study
by Sandhu, Manjinder S, Dr
The Lancet (British edition), 2008, Vol.371 (9611), p.483-491
2.
Sudden unexplained death: evaluation of those left behind
by Lee, Adriana
The Lancet (British edition), 2003-11-01, Vol.362 (9394), p.1429-1431
3.
Genotype-specific effects of smoking on risk of CHD
by Li Wang, Xing
The Lancet (British edition), 2001, Vol.358 (9276), p.87-88
4.
Association studies of genetic polymorphisms and complex disease
by Cheung, Bernard MY
The Lancet (British edition), 2000-04-08, Vol.355 (9211), p.1277-1277
5.
Association studies of genetic polymorphisms and complex disease
by Sharma, Arya M
The Lancet (British edition), 2000-04-08, Vol.355 (9211), p.1277-1277
6.
Association studies of genetic polymorphisms and complex disease
by Chowdhury, Tahseen A
The Lancet (British edition), 2000-04-08, Vol.355 (9211), p.1277-1278
7.
Association studies of genetic polymorphisms and complex disease
by Cappuccio, Francesco P
The Lancet (British edition), 2000-04-08, Vol.355 (9211), p.1278-1278
8.
Association of maternal G protein beta3 subunit 825T allele with low birthweight
by Hocher, B
The Lancet (British edition), 2000-04-08, Vol.355 (9211), p.1241-1242
9.
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
by Voight, Benjamin F, PhD
The Lancet (British edition), 2012-08-11, Vol.380 (9841), p.572-580
10.
Clinical assessment incorporating a personal genome
by Ashley, Euan A, Dr
The Lancet (British edition), 2010, Vol.375 (9725), p.1525-1535
11.
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
by Mega, Jessica L, Dr
The Lancet (British edition), 2015, Vol.385 (9984), p.2264-2271
12.
HDL and cardiovascular disease
by Rader, Daniel J, Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.618-625
13.
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
by Sarwar, Nadeem
The Lancet (British edition), 2012, Vol.379 (9822), p.1205-1213
14.
Triglycerides and cardiovascular disease
by Nordestgaard, Børge G, Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.626-635
15.
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
by Holmes, Michael V
The Lancet (British edition), 2012, Vol.379 (9822), p.1214-1224
16.
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
by Sarwar, Nadeem
The Lancet (British edition), 2010, Vol.375 (9726), p.1634-1639
17.
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLAT...
by Wallentin, Lars, Prof
The Lancet (British edition), 2010, Vol.376 (9749), p.1320-1328
18.
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase...
by Greenberg, Barry, Prof
The Lancet (British edition), 2016-03-19, Vol.387 (10024), p.1178-1186
19.
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses
by Ripatti, Samuli, Dr
The Lancet (British edition), 2010, Vol.376 (9750), p.1393-1400
20.
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wi...
by Reilly, Muredach P, Dr
The Lancet (British edition), 2011, Vol.377 (9763), p.383-392
Filter electronic articles 173 Hits
Remove Filters
- Journal Title
- The Lancet
- Lancet (5)